The global sales of vascular patches is estimated to be worth USD 160.3 million in 2024 and anticipated to reach a value of USD 256.2 million by 2034. Sales are projected to rise at a CAGR of 4.8% over the forecast period between 2024 and 2034. The revenue generated by Vascular Patches in 2023 was USD 153.0 million.
By 2024, the global market for synthetic and biologic vascular patches is anticipated to be evenly divided. This equilibrium is driven by advancements in material science and biotechnology, which have enhanced the effectiveness and compatibility of both patch types with human tissues.
Both Synthetic patches and biologic patches have their own benefits. While synthetic patches exhibit durability, consistent quality and scalability, biological patches easily and seamlessly blend into natural tissue, and are known to have a low infection rate. These technologies support the medical community to cater to a diverse patient population.
Global Vascular Patches Industry Assessment
| Attributes | Key Insights |
|---|---|
| Historical Size, 2023 | USD 153.0 million |
| Estimated Size, 2024 | USD 160.3 million |
| Projected Size, 2034 | USD 256.2 million |
| Value-based CAGR (2024 to 2034) | 4.8% |
Over 65% of the market revenue is generated by key procedures such as Carotid Endarterectomy, Vascular Bypass Surgery, and Peripheral Vascular Reconstruction. Prevalence of vascular diseases, rise in diagnostic rates, improved efficacy and technology advancements are some of the driving factors of this market.
Hospitals dominate the utilization of these patches, comprising over 40% of the market. However, as trauma cases rise and efforts in research and development intensify, which anticipate moderate growth in the adoption of vascular patches by trauma care centers and academic institutions.
The forecast period anticipates substantial growth in the vascular patches industry, with an incremental opportunity of USD 95.5 million. Projections indicate that the market will expand to 1.6 times its current value by 2034.
Increasing adoption of vascular patches in endovascular interventions is observed, driven primarily by minimally invasive surgical procedures that promise quicker recoveries and fewer complications. Moreover, it is expected that adding to the increasing burden of cardiovascular diseases in the elderly population, growing healthcare infrastructure, and rising awareness of CVD will further boost the market growth.
While technological advancement serves as the key driver, it is associated with a high production cost that may lower accessibility in certain regions, ultimately affecting market penetration.
Furthermore, inadequate reimbursement policies for vascular surgeries could be a key limiting factor in some regions. Risk of complications, and choice of alternative treatment options that include medication, changes in lifestyle, could result in a lower adoption of vascular surgeries thereby restricting market growth.
Don't pay for what you don't need
Customize your report by selecting specific countries or regions and save 30%!
The above table presents the expected CAGR for the global vascular patches market over several semi-annual periods spanning from 2024 to 2034. In the first half (H1) of the decade from 2023 to 2033, the business is predicted to surge at a CAGR of 5.6%, followed by a slightly higher growth rate of 5.1% in the second half (H2) of the same decade.
| Particular | Value CAGR |
|---|---|
| H1 | 5.6% (2023 to 2033) |
| H2 | 5.1% (2023 to 2033) |
| H1 | 4.8% (2024 to 2034) |
| H2 | 4.5% (2024 to 2034) |
Moving into the subsequent period, from H1 2024 to H2 2034, the CAGR is projected to decrease slightly to 4.8% in the first half and increase moderately at 4.5% in the second half. In the first half (H1) the market witnessed a decrease of 80 BPS while in the second half (H2), the market witnessed a decrease of 62 BPS.
Unleashing Growth: The Vascular Patches Market is growing amidst Surging Vascular Diseases
Rise in Vascular diseases is the primary factor contributing to the expansion of the market. With aging population, there is a rise in conditions such as atherosclerosis and peripheral artery diseases. Addressing these conditions often necessitates the use of vascular patches.
For Instance in the USA approximately 8.5 million people are affected by peripheral artery disease, of which nearly 12 to 20% represent people 60 years and older.
Some of the key factors that contribute to this in the USA are smoking, hypertension, and other similar lifestyle disorders that is common among the older population in USA Similarly, in the UK over 100,000 hospital admissions are recorded every year that are associated with atherosclerosis.
This advancement in minimally invasive techniques has really upped the success rate of vascular surgeries, and thereby increases the demand for quality vascular patches. There is very strong R&D going on in devising novel materials and technologies for vascular patches, which will raise biocompatibility and reduce the risks of infection and rejection.
Incidence of heart diseases and other disorders of the cardio system is rising, so goes the frequency of cardio surgeries, and in proportion, the vascular patch market will be in demand now and in the future. With the rise of vascular diseases worldwide, the demand for surgical interventions also increases. Vascular patches play a vital role of restoring normal blood flow making them a key product to consider in such procedures.
Harnessing the Potential of Minimally Invasive Techniques is Creating Opportunities for Vascular Patches Industry
Minimally invasive procedures such as endovascular surgeries have significant benefits over the traditional open surgeries. For an instance these procedures provide advantages like small incision, less pain, short hospital stay and faster recovery time. These advantages contribute to enhanced patient satisfaction.
Procedures such as angioplasty and stenting require advanced vascular patches to minimize tissue damage. With the rising demand for minimally invasive procedures the vascular patches market is evolving to meet the new needs and demands. The industry is evolving through innovations in this space.
Innovations such as catheter-based delivery systems, advancements in imaging technology, and enhancements in medical devices are the key factors that are driving this evolution. Some of the key changes or technology updates seen in this space include bioresorbable material-based vascular patches and drug-eluting patches.
The past decade has seen a surge in endovascular surgeries in the USA that has increased by 50%. This type of trend towards minimally invasive surgeries not confined only to the USA Europe is also experiencing the rise in uptake of minimally invasive surgeries that is supported by updated healthcare policies that focus on cost reduction and betterment of patient care.
In essence, this shift towards minimally invasive procedures is only beginning and yet to reach its peak. As healthcare systems worldwide prioritize cost-effective, patient-friendly treatment options, the demand for innovative vascular patches that support these techniques will continue to surge, driving further growth in the industry.
Regulatory Hurdles is a Barrier for New Entrants in the Vascular Patches Industry
Entering the vascular patches market isn't without its challenges, especially for newcomers. Regulations imposed by the USA FDA and European Medicines Agency (EMA) are stringent and pose significant hurdles in the approval process. This costs the manufactures significant time.
While regulations by these bodies are meant for patient safety, they also entail substantial cost and time for manufacturers to navigate. This protracted approval process not only impacts market competition but also stifles innovation and product development.
Small businesses are the ones that are the most affected but these stringent regulations as they face barriers due to limited financial resources. Clinical trials are the most time and cost consuming steps for these small players. Furthermore, variations in regulations across different regions added to the complexity of gaining market entry for new entrants and product development.
This means heavy investments in research and development, and complex regulatory pathways to entry for new entrants. Even the clinical trials can be very expensive in terms of the procedures involved in patient recruitment, monitoring, and the analysis of data, thereby making this out of reach for smaller companies with limited funding.
The approval process itself can take a very long time and is relatively uncertain. These agencies may require several rounds of submission and query responses that take up to years, thus delaying the launch of products. Such uncertainties in regulatory approval create a problem for financial planning in a company, market strategy, and also make investment and partnership difficult to secure.
Principal Consultant
The global vascular patches industry recorded a CAGR of 3.2% during the historical period between 2019 and 2023. The growth of vascular patches industry was positive as it reached a value of USD 153.0 million in 2023 from USD 123.4 billion in 2019.
Advanced bioengineering solutions opens new opportunities in the vascular patches industry. There is a rising demand for more effective and biocompatible options, this is the primary driver for most manufacturers to push boundaries of innovation and develop patches that integrate seamlessly and support better healing.
Bioresorbable vascular patches dissolve slowly inside the human body, drastically reducing the potential risk of further surgeries and shortening, to a colossally great extent, the recovery time of patients.
Bioresorbable vascular patches are just the beginning. The development of drug-eluting patches, designed to deliver specific drugs like anti-inflammatory agents, represents a new and exciting innovation in the vascular patch industry. Further, 3D bioprinting technology gives options for customization that best suits personalized medicine to meet the unique needs of the individual patient.
Tier 1 companies comprise market leaders with a market revenue of above USD 100 million capturing significant market share of 64.6% in global market. These market leaders are characterized by high production capacity and a wide product portfolio. These market leaders are distinguished by their extensive expertise in manufacturing and reconditioning across multiple packaging formats and a broad geographical reach, underpinned by a robust consumer base.
They provide a wide range of series including reconditioning, recycling, and manufacturing utilizing the latest technology and meeting the regulatory standards providing the highest quality. Prominent companies within tier 1 include Getinge AB (Maquet), LeMaitre Vascular, Inc., and B. Braun Melsungen AG.
Tier 2 companies include mid-size players with revenue of USD 50 to 100 million having presence in specific regions and highly influencing the local market and holds around 31.7% market share. These are characterized by a strong presence overseas and strong market knowledge.
These market players have good technology and ensure regulatory compliance but may not have advanced technology and wide global reach. Prominent companies in tier 2 include Edwards Lifesciences, Baxter International, Terumo Corporation, and CryoLife among others.
Finally, Tier 3 companies, such as Braile Biomedica, Labcor Laboratórios, and W. L. Gore & Associates, while smaller, are essential for the market.
Get the data you need at a Fraction of the cost
Personalize your report by choosing insights you need
and save 40%!
The section below covers the industry analysis for the vascular patches market for different countries. Market demand analysis on key countries in several regions of the globe, including North America, Asia Pacific, Europe, and others, is provided. The United States is anticipated to remain at the forefront in North America, with a value share of 91.7% through 2034. In Asia Pacific, South Korea is projected to witness a CAGR of 5.8% by 2034.
| Countries | Value CAGR (2024 to 2034) |
|---|---|
| Canada | 5.5% |
| Argentina | 2.4% |
| France | 5.0% |
| Russia | 3.8% |
| Indonesia | 2.3% |
| South Korea | 5.8% |
| GCC Countries | 6.4% |
USA Vascular Patches market is poised to exhibit a CAGR of 6.6% between 2024 and 2034, reaching over USD 80.1 million by 2034. Currently, it holds the highest share in the North American market, and the trend is expected to continue during the forecast period.
Rise in number of older population, evolving lifestyle changes that negatively impact dietary choices, promote sedentary habits, and smoking contribute to the rise in vascular disease. For an instance in the USA alone, the American Heart Association reports that approximately 8.5 million people are affected by PAD.
Furthermore, comprehensive insurance coverage in the USA extends to a wide array of medical procedures that also include vascular surgeries. This allows easy access to advanced treatments that surges the number of surgeries and use of advanced products such as carotid endarterectomy, vascular bypass surgery, and peripheral vascular reconstruction, all of which rely heavily on the utilization of vascular patches to ensure successful outcomes.
East Asia, spearheaded by China currently holds around 44.0% share of the East Asia vascular Patches industry. East Asia’s market is anticipated to grow at a CAGR of 8.1% throughout the forecast period, amounting to a valuation of USD 40.5 Million by 2034.
Rapid urbanization is causing a shift in lifestyle across China. This is leading to significant health challenges including significant rise in conditions like diabetes and hypertension.
These conditions further increase the risk of vascular diseases. Rise in vascular diseases is the primary factor for driving the demand for vascular surgeries and there by vascular patches. Concurrently, advancements in healthcare further improve access to advance medical treatments to a large chunk of the population in China.
Disappearing middle class in China indicates that there is a rise in disposable income. These individuals are seeking enhanced healthcare services, and sophisticated medical procedures that include use of vascular patches.
Furthermore, the government in China is actively working towards initiatives that enhance healthcare services and reduce impact of chronic diseases. One of the key initiatives is investment in medical research that promotes innovation in the medical arena. Rapidly growing cities, changing lifestyles has led to increasing number of people having increased risk of cardiovascular diseases.
This has created a greater need for vascular patches used in surgeries to address these issues. Alongside this, improvements in healthcare infrastructure mean more people in China can access advanced medical treatments.
Germany is expected to have a strong foothold when it comes to technology innovation. In 2023 the country is projected to account for almost 22.7% of the European Vascular Patches Market.
Germany is known to develop some of the world’s most cutting-edge medical technologies and has a very robust healthcare infrastructure. Leveraging state-of-the-art medical devices and highly skilled vascular surgery professionals, patients benefit from top-tier care. Well-equipped hospitals and clinics, with advanced medical technologies ensures seamless access to key medical devices like advanced vascular patches for the patients in need in the country.
Moreover, the regulatory framework and quality standards in Germany provide an excellent base for producing top-notch medical devices. In view of the rather strict procedure involved in certification processes, and particularly attaining international standards, it is ensured that German-made vascular patches are of unsurpassed quality both in respect of safety and efficacy.
These were some of the major factors that boosted the demand for German vascular patches first at home, then abroad. Such trust in Germany's products instills confidence in healthcare providers the world over, which has been one of the triggers toward global market expansion.
The section contains information about the leading segments in the industry. By material, the biologic patches segment is estimated to grow at a CAGR of 4.9% throughout 2034. Additionally, the synthetic patches industry is projected to expand at 6.8% till 2034.
| Material | Biologic |
|---|---|
| Value Share (2024) | 50.7% |
In 2024, the biologic patches segment emerges as the revenue leader, commanding nearly 51% of the market share. Although the adoption rates for both biologic and synthetic patches are currently similar, biologic patches are anticipated to gain traction over the forecast period, ultimately claiming dominance in the market.
The most common activity in this market is the continuous development of biologic patches. With advancements in material research, it has become possible to develop patches that more and more closely replicate the properties of natural tissue and thus support faster and better healing.
This significantly minimizes the number of repeat surgeries and the resultant rate of complications that come along with them. This factor has thus come to make the biologic patches more attractive for use in vascular interventions among patients.
Biologic patches provide patients with the advantage of better outcomes and less adverse reactions because they are very much compatible with natural tissue. The trends in biologic materials and techniques have been further accelerated for adoption in clinical practice and are probably one of the preferred choices for vascular surgeries.
Therefore, it will assume prime of place in the market in the long run through a combination of advantages such as biocompatibility, natural integration, reduced need for additional surgeries, and decreased risk of complications associated with biologic vascular patches.
| End Use | Hospitals |
|---|---|
| Value Share (2034) | 45.0% |
The hospitals segment is forecast to account for a revenue of over USD 108.6 million in the Vascular Patches market by 2034 end. It is also poised to expand at a CAGR of 7.0% across the forecast period.
Since most of the vascular surgeries are conducted in hospital based settings, the adoption of vascular patches in hospitals is the highest making it the dominant segment among all end users. Hospitals handle a significant volume of both emergency and schedules surgeries because this segment is supported with cutting edge technologies, good number of specialized personnel that can ensure the best care for patients.
Additionally, hospitals are known to be a part of a large number of clinical trials and research based studies that results in higher uptake of advanced medical devices including vascular patches. Healthcare services, spanning from diagnostics to treatment and postoperative care, solidify hospitals as the largest consumers of vascular patches in the market.
Substantial investments are seen in the vascular patches industry towards research and development in order to drive innovations such as bioresorbable, drug eluting patches and research for enhancing biocompatibility. Another key strategic focus of these companies is to actively look for strategic partners to bolster their product portfolios and expand their global market presence.
Recent Industry Developments in Vascular Patches Market
In terms of material, the industry is divided into biologic, and synthetic.
In terms of application, the industry is segregated into Carotid Endarterectomy, Open Repair of Abdominal Aneurysm, Vascular Bypass Surgery, Peripheral vascular reconstruction, and others.
The industry is classified by end user as hospitals, trauma care centres and academic & research institutes.
Key countries of North America, Latin America, East Asia, South Asia & Pacific, Western Europe, Eastern Europe and Middle East & Africa have been covered in the report.
The global vascular patches industry is projected to witness CAGR of 4.8% between 2024 and 2034.
The global vascular patches industry stood at USD 153.0 million in 2023.
The global vascular patches industry is anticipated to reach USD 256.2 million by 2034 end.
India is set to record the highest CAGR of 5.8% in the assessment period.
The key players operating in the global vascular patches industry include Baxter International, Getinge Ab (Maquet) and B. Braun Melsungen AG.
1. Executive Summary
2. Industry Introduction, including Taxonomy and Market Definition
3. Market Trends and Success Factors, including Macro-economic Factors, Market Dynamics, and Recent Industry Developments
4. Global Market Demand Analysis 2019 to 2023 and Forecast 2024 to 2034, including Historical Analysis and Future Projections
5. Global Market Analysis 2019 to 2023 and Forecast 2024 to 2034
5.1. By Material
5.2. By Application
5.3. By End User
5.4. By Region
6. Global Market Analysis 2019 to 2023 and Forecast 2024 to 2034, by Material
6.1. Synthetic vascular patches
6.2. Biologic vascular patches
7. Global Market Analysis 2019 to 2023 and Forecast 2024 to 2034, by Application
7.1. Carotid Endarterectomy
7.2. Open Repair of Abdominal Aneurysm
7.3. Vascular bypass Surgery
7.4. Peripheral vascular reconstruction
7.5. Others
8. Global Market Analysis 2019 to 2023 and Forecast 2024 to 2034, by End User
8.1. Hospitals
8.2. Trauma Care Centers
8.3. Academic & Research Institutes
9. Global Market Analysis 2019 to 2023 and Forecast 2024 to 2034, by Region
9.1. North America
9.2. Latin America
9.3. East Asia
9.4. South Asia and Pacific
9.5. Western Europe
9.6. Eastern Europe
9.7. Middle East and Africa
10. North America Sales Analysis 2019 to 2023 and Forecast 2024 to 2034, by Key Segments and Countries
11. Latin America Sales Analysis 2019 to 2023 and Forecast 2024 to 2034, by Key Segments and Countries
12. East Asia Sales Analysis 2019 to 2023 and Forecast 2024 to 2034, by Key Segments and Countries
13. South Asia & Pacific Sales Analysis 2019 to 2023 and Forecast 2024 to 2034, by Key Segments and Countries
14. Western Europe Sales Analysis 2019 to 2023 and Forecast 2024 to 2034, by Key Segments and Countries
15. Eastern Europe Sales Analysis 2019 to 2023 and Forecast 2024 to 2034, by Key Segments and Countries
16. Middle East and Africa Sales Analysis 2019 to 2023 and Forecast 2024 to 2034, by Key Segments and Countries
17. Sales Forecast 2024 to 2034 by Material, Application, and End User for 30 Countries
18. Competition Outlook, including Market Structure Analysis, Company Share Analysis by Key Players, and Competition Dashboard
19. Company Profile
19.1. Braile Biomedica
19.2. Baxter International
19.3. Getinge Ab (Maquet)
19.4. B. Braun Melsungen AG
19.5. W. L. Gore & Associates
19.6. Admedus
19.7. Cryolife
19.8. Edwards Lifesciences
19.9. Labcor Laboratórios
19.10. Terumo Corporation
19.11. BiOTECK
19.12. Lab medica
19.13. Tissuemed
19.14. InSitu Technologies
19.15. LeMaitre Vascular, Inc.
19.16. Becton, Dickinson and Company
19.17. CARITAS
Explore Healthcare Insights
View Reports
Vascular Patches Market
